ArticleCancer discovery2025

Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12C.

Anna E Maciag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.